期刊文献+

和厚朴酚体外抗胆囊癌作用及机制研究 被引量:7

Inhibitory effect of honokiol against gallbladder cancer in vitro and its mechanism
原文传递
导出
摘要 目的:探讨和厚朴酚在体外对胆囊癌细胞生长的影响及机制。方法:用CCK-8法检测和厚朴酚对胆囊癌SGC-996细胞的抑制作用,并计算其半数抑制浓度(I_(50));用不同浓度和厚朴酚作用SGC-996细胞48 h后,分别用平板克隆形成试验、流式细胞术,Western blot法检测细胞克隆形成、凋亡与细胞周期情况,以及凋亡及细胞周期相关蛋白的表达。结果:和厚朴酚能明显抑制SGC-996细胞的生长,其24、48、72 h的I_(50)分别为34.66、23.20、18.87μmol/L。和厚朴酚处理后的SGC-996细胞克隆细胞团数减少,细胞的凋亡率与G0/G1期细胞百分比增加,促凋亡蛋白(Bax、cleaved-caspase-9、cleaved-caspase-3、cleaved-PARP)表达升高、抗凋亡蛋白(Bcl-2、Bcl-2/Bax比值)与细胞周期相关蛋白(Cyclin D1、Cdk4、Cdk6)表达降低,且均呈明显的浓度依赖趋势(均P<0.05)。结论:和厚朴酚在体外对胆囊癌细胞有明显的抑制作用,其机制可能是通过启动细胞凋亡内始式途径诱导细胞凋亡,并且通过调节细胞周期相关蛋白的表达抑制细胞的增殖。 Objective: To investigate the effect of honokiol on the growth of gallbladder cancer cells in vitro and its mechanism.Methods: Using CCK-8 assay, the inhibitory ef ect of honokiol on gallbladder cancer SGC-996 cells was observed and the 50% inhibitory concentration(IC50) values were calculated. At er exposure of SGC-996 cells to dif erent concentrations of honokiol for 48 h, the colony formation, apoptosis and cell cycle as well as the expressions of apoptosis and cell cycle related proteins were examined by plate colony formation assay, cytometry and Western blot analysis, respectively.Results: Honokiol signii cantly inhibited the growth of SGC-996 cells, and its I50 value was 34.66, 23.20 and 18.87 μmol/L after 24, 48 and 72 h, respectively. After exposure of SGC-996 cells to honokiol, the number of colony forming units was decreased, apoptosis rate and percentage of G0/G1 cells were increased, and theexpressions of pro-apoptotic proteins(Bax, cleaved-caspase-9, cleaved-caspase-3 and cleaved-PARP) were increased, while expressions of anti-apoptotic proteins(Bcl-2 and Bcl-2/Bax ratio) as well as cell cycle-related proteins(Cyclin D1, Cdk4 and Cdk6) were decreased. All of these effects showed significant concentrationdependent trend(all P〈0.05).Conclusion: Honokiol has strong inhibitory effect on gallbladder cancer cells in vitro, and its mechanism may possibly be associated with inducing cell apoptosis via intrinsic apoptosis pathway and suppressing cell proliferation by regulating the expression of cell cycle-related proteins.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2016年第2期231-237,共7页 China Journal of General Surgery
关键词 胆囊肿瘤 和厚朴酚 细胞凋亡 细胞周期 Gallbladder Neoplasms HONOKIOL Apoptosis Cell Cycle
  • 相关文献

参考文献27

  • 1Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder[J]. Lancet Oncol, 2003, 4(3):167-176.
  • 2张明迪,龚伟,郑莹,张勇,周迪,吴春晓,翁明哲,杨勇,全志伟.上海市胆囊癌流行状况和趋势分析[J].中国实用外科杂志,2013,33(8):691-694. 被引量:27
  • 3Miller G, Jarnagin WR. Gallbladder carcinoma[J]. Eur J Surg Oncol, 2008, 34(3):306-312.
  • 4石景森,郑见宝.进一步提高胆囊癌诊治的总体水平[J].临床肝胆病杂志,2013,29(6):401-403. 被引量:10
  • 5毛拉艾沙·买买提,依马木买买提江·阿不拉,薛峰.胆囊癌的外科疗效及预后影响因素分析[J].中国普通外科杂志,2012,21(9):1166-1169. 被引量:8
  • 6Williams TM, Majithia L, Wang SJ, et al. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer[J]. Semin Radiat Oncol, 2014, 24(2):94-104.
  • 7He Z, Subramaniam D, Zhang Z, et al.Honokiol as a Radiosensitizing Agent for Colorectal cancers[J]. Curr Colorectal Cancer Rep, 2013, (4). doi: 10.1007/s11888-013-0191-4.
  • 8Wang XD, Wang YL,Gao WF. Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment[J]. Int J Clin Exp Pathol, 2015, 8(7):7929-7936.
  • 9Tripathi S, Chan MH, Chen C. An expedient synthesis of honokiol and its analogues as potential neuropreventive agents[J]. Bioorg Med Chem Lett, 2012, 22(1):216-221.
  • 10Liu Y, Chen L, He X, et al. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma[J]. Int J Gynecol Cancer, 2008, 18(4):652-659.

二级参考文献41

  • 1唐志宇,吴育连,高顺良,沈宏伟.胆囊癌术后感染性并发症的危险因素分析[J].实用肿瘤杂志,2007,22(1):54-58. 被引量:2
  • 2陈永亮,黄志强,周宁新,张文智,黄晓强,段伟东,刘荣,刘洋.原发性胆囊癌110例临床分析[J].中华肿瘤杂志,2007,29(9):704-706. 被引量:28
  • 3Meng H, Wang X, Fong Y, et al. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases[J]. Jpn J Clin Oncol, 2011, 41(8):992-998.
  • 4Hueman MT, Vollmer CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer[J]. Ann Surg Oncol, 2009, 16(8):2101-2115.
  • 5Liu C, Sun B, An N, et al. Inhibitory effect of Survivin promoter- regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer[J]. Mol Oncol, 2011, 5(6):545-554.
  • 6Cho SY, Park SJ, Kim SH, et al. Comparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience[J]. World J Surg, 2010, 34(7): 1572-1578.
  • 7Choi SB, Han HJ, Kim CY, et al. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival[J]. Hepatogastroenterology, 2012, 59(113):36-41.
  • 8Khan RA, Wahab S, Khan MA, et al. Advanced presentation of gallbladder cancer: epidemioclinicopathological study to evaluate the risk factors and assess the outcome[J]. J Pak Med Assoc, 2010, 60(3):217-219.
  • 9石景森,孙学军.原发性胆囊癌诊治的历史、现状及展望[J].西安交通大学学报(医学版),2007,28(5):473-477. 被引量:39
  • 10Ferlay J ,Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010 , 127(12):2893-2917.

共引文献42

同被引文献114

引证文献7

二级引证文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部